CIK 0001746466
- Non-accelerated filer
- Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821554746
- Phone
- +1 858-412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $4.52 ($113,045)
- 4 Open-market sale Chief Financial Officer sold 8,000 shares at $4.74 ($37,914)
- 4 Other acquisition Chief Financial Officer acquired 5,362 shares (other)
- 4 Other acquisition Sr. Vice President and COO acquired 1,097 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $5.62 ($140,395)
- 4 Open-market sale Chief Scientific Officer sold 250,000 shares at $8.13 ($2,033,475)
- 4 Other acquisition Chief Financial Officer acquired 5,014 shares (other)
- 4 Other acquisition Sr. Vice President and COO acquired 9,570 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 9 · 177 filings